Wednesday, March 16, 2011

Another set back for Obesity fight - Amylin halts obesity drug study

It is a sad day I must say, Amylin and Takeda halted their Obesity drug study. This might be good news for Arena but certainly bad news for Obese population that are running out of options.

Article from Minyanville

FDA are you listening? Diet and Exercise are not enough to fight obesity we need more options fight this battle.